13F filer · CIK 886982 ↗
Goldman Sachs Group Inc
You are looking at Q4 2018. See the latest, Q2 2026 →
Reported value
$313.71B
−19% on the quarter before
Positions
5,188
529 new · 890 sold out
Top 10
13.8%
of the value
Est. gain
−$44.19B
on stocks held all quarter
Est. return
−15.2%
on those stocks since Q3 2018
Positions as of Dec 31, 2018, from Goldman Sachs Group Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 22% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2018. Striped tiles are options.
Largest buys
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Energy Transfer Lp~$1.18BAdded · 0.2% → 0.6%+89,109,374 shares
- Ishares Tr~$1.08BAdded · 0.4% → 0.8%+13,321,613 shares
- Ishares TrPUT~$1.08BAdded · 0.1% → 0.5%+13,285,200 underlying
- SPDR Series TrustPUT~$803.5MAdded · 0.1% → 0.3%+30,286,700 underlying
- Merck & Co Inc~$788.1MAdded · 0.3% → 0.6%+10,314,634 shares
- Starbucks Corp~$708.2MAdded · 0.1% → 0.4%+10,996,405 shares
- TSMC~$521.3MAdded · 0.1% → 0.3%+14,124,107 shares
- TeslaPUT~$508.5MAdded · 0.2% → 0.4%+1,527,900 underlying
- SPDR Gold TrustPUT~$438.1MAdded · 0.0% → 0.2%+3,613,100 underlying
- Cigna Corp New~$434.2MNew · 0.0% → 0.1%+2,286,420 shares
Largest sells
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrPUT~$3.06BCut · 2.2% → 1.4%−12,229,400 underlying
- Energy Transfer Partners Lp~$1.64BSold out · 0.4% → 0.0%−73,582,373 shares
- Invesco Qqq TrPUT~$1.11BCut · 0.7% → 0.3%−7,188,700 underlying
- Ishares TrCALL~$876.0MCut · 0.3% → 0.1%−10,801,000 underlying
- SPDR Gold TrustCALL~$758.3MCut · 0.7% → 0.7%−6,254,000 underlying
- Ishares Tr~$721.6MCut · 0.3% → 0.1%−6,395,801 shares
- Express Scripts Hldg Co~$712.8MSold out · 0.2% → 0.0%−7,502,173 shares
- Rockwell Collins Inc~$609.6MSold out · 0.2% → 0.0%−4,339,746 shares
- Andeavor~$570.3MSold out · 0.1% → 0.0%−3,715,139 shares
- Aetna Inc New~$519.1MSold out · 0.1% → 0.0%−2,559,159 shares
Holdings
As of Dec 31, 2018. Changes are in shares against Sep 30, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPDR S&P 500 ETF TrCMN · shares +3.0% · price −14.0% | 3.6% | $11.44B | −$1.81B | ||||||||
| AppleCMN · shares −5.1% · price −30.1% | 1.7% | $5.25B | −$2.26B | ||||||||
| SPDR S&P 500 ETF TrPUTCMN · shares −41% | 1.4% | $4.38B | — | ||||||||
| MicrosoftCMN · shares −11% · price −11.2% | 1.3% | $4.07B | −$512.6M | ||||||||
| SPDR S&P 500 ETF TrCALLCMN · shares −12% | 1.2% | $3.70B | — | ||||||||
| AmazonCMN · shares −9.9% · price −25.0% | 1.1% | $3.59B | −$1.20B | ||||||||
| AlibabaCMN · shares +11% · price −16.8% | 0.93% | $2.91B | −$528.8M | ||||||||
| Ishares TrCMN · shares −11% · price −20.6% | 0.88% | $2.76B | −$715.4M | ||||||||
| Ishares TrCMN · shares +10% · price −13.5% | 0.85% | $2.66B | −$378.4M | ||||||||
| MetaCMN · shares +13% · price −20.3% | 0.84% | $2.63B | −$590.5M | ||||||||
| Visa Inc.CMN · shares −1.0% · price −12.1% | 0.77% | $2.41B | −$331.2M | ||||||||
| Ishares TrCMN · shares +83% · price −6.2% | 0.76% | $2.39B | −$86.2M | ||||||||
| SPDR Gold TrustCALLCMN · shares −26% | 0.70% | $2.21B | — | ||||||||
| AlphabetCMN · shares −10% · price −13.4% | 0.65% | $2.05B | −$318.2M | ||||||||
| Johnson & JohnsonCMN · shares +3.4% · price −6.6% | 0.64% | $2.02B | −$137.9M | ||||||||
| Invesco Qqq TrCMN · shares −10% · price −17.0% | 0.64% | $1.99B | −$407.5M | ||||||||
| Merck & Co IncCMN · shares +71% · price +7.7% | 0.60% | $1.89B | +$79.1M | ||||||||
| Energy Transfer LpCMN · shares +175% · price −24.2% | 0.59% | $1.85B | −$214.7M | ||||||||
| Jpmorgan Chase & CoCMN · shares −2.3% · price −13.5% | 0.56% | $1.76B | −$274.4M | ||||||||
| AlphabetCMN · shares −12% · price −13.2% | 0.54% | $1.71B | −$260.1M | ||||||||
| Pfizer IncCMN · shares −5.2% · price −1.0% | 0.54% | $1.69B | −$16.3M | ||||||||
| Berkshire Hathaway Inc DelCMN · shares −3.7% · price −4.6% | 0.51% | $1.60B | −$77.8M | ||||||||
| Ishares TrPUTCMN · shares +217% | 0.50% | $1.57B | — | ||||||||
| CiscoCMN · shares −8.6% · price −10.9% | 0.46% | $1.44B | −$176.5M | ||||||||
| Bank Amer CorpCMN · shares +8.3% · price −16.4% | 0.44% | $1.39B | −$251.9M | ||||||||
| Total · 5,188 positions | 100% | $313.71B | −$44.19B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2018 to Q4 2018: 3,642 stocks held throughout, down $44.19B (−15.2%).
- Procter And Gamble Co+$115.5M+10%
- Merck & Co Inc+$79.1M+8%
- Tesla+$74.2M+26%
- Verizon Communications Inc+$67.0M+5%
- Red Hat Inc+$62.1M+29%
- Meta−$590.5M−20%
- Ishares Tr−$715.4M−21%
- Amazon−$1.20B−25%
- SPDR S&P 500 ETF Tr−$1.81B−14%
- Apple−$2.26B−30%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 32 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $1.15T+32% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $870.94B+7% | SEC ↗ |
| Q4 2025 | Mar 25, 2026 (amended) | $815.35B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $817.38B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $736.09B+19% | SEC ↗ |
| Q1 2025 | Jun 27, 2025 (amended) | $617.84B−3% | SEC ↗ |
| Q4 2024 | Feb 11, 2025 | $634.40B+2% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $621.07B+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $591.35B+5% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.15B+4% | SEC ↗ |
| Q4 2023 | May 14, 2024 (amended) | $542.58B+15% | SEC ↗ |
| Q3 2023 | May 15, 2024 (amended) | $470.08B+1% | SEC ↗ |
| Q2 2023 | May 14, 2024 (amended) | $466.39B+7% | SEC ↗ |
| Q1 2023 | May 14, 2024 (amended) | $435.29B+7% | SEC ↗ |
| Q4 2022 | May 14, 2024 (amended) | $407.90B+102,967% | SEC ↗ |
| Q3 2022 | May 14, 2024 (amended) | $395.8M−1% | SEC ↗ |
| Q2 2022 | May 14, 2024 (amended) | $400.2M−100% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $476.17B−5% | SEC ↗ |
| Q4 2021 | Feb 17, 2022 (amended) | $503.62B+7% | SEC ↗ |
| Q3 2021 | Jan 20, 2022 (amended) | $471.46B+6% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $446.39B+13% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $396.45B+2% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $388.63B+10% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $352.35B+7% | SEC ↗ |
| Q2 2020 | Aug 12, 2020 | $329.38B+16% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $283.84B−28% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $392.61B+13% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $346.13B−0% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $347.49B+5% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $331.01B+6% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $313.71B−19% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $387.28B+5% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $369.55B−5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $390.88B−7% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $418.15B+2% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $408.33B+6% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $386.49B+5% | SEC ↗ |
| Q1 2017 | May 18, 2017 (amended) | $368.56B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $353.62B+7% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $330.24B+8% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $306.30B+1% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $304.14B | SEC ↗ |